These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3347008)

  • 1. [Which laboratory parameters are useful and necessary in fibrinolytic therapy?].
    Theiss W
    Klin Wochenschr; 1988; 66 Suppl 12():55-8. PubMed ID: 3347008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of laboratory diagnosis in thrombolytic therapy].
    Sosada ME; Gulba DC
    Z Gesamte Inn Med; 1993; 48(6-7):289-95. PubMed ID: 8333225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Laboratory monitoring of thrombolytic therapy in clinical practice and research].
    Grünewald M; Seifried E
    Z Kardiol; 1993; 82 Suppl 2():129-35. PubMed ID: 8328190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Normal values of hemoglobin, hematocrit, blood coagulation factors, and fibrinolysis in New Zealand white rabbits].
    Marval E; García L; Candela DE; Arocha-Piñango CL
    Sangre (Barc); 1992 Oct; 37(5):355-61. PubMed ID: 1293775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
    Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
    Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activator time. A method for control of activator activity during thrombolytic therapy.
    Blix S
    Scand J Haematol; 1969; 6(4):221-6. PubMed ID: 5388562
    [No Abstract]   [Full Text] [Related]  

  • 11. [Normal values for hematological and hemostatic parameters in the rabbit. Determination of new parameters for experimental models of thrombosis and hemostasis].
    Monreal L; Anglés AM; Ruiz de Gopegui R; Espada Y; Monasterio J; Roncalés FJ; Monreal M
    Sangre (Barc); 1993 Oct; 38(5):365-9. PubMed ID: 8140497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The seial thrombin time in the diagnosis of consumptive coagulopathy.
    Alonso KB
    Ann Clin Lab Sci; 1978; 8(3):228-33. PubMed ID: 655608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood coagulation and fibrinolytic factors as well as their inhibitors in trauma.
    Blombäck M; Eklund J; Hellgren M; Lagerkranser M; Swedenborg J
    Scand J Clin Lab Invest Suppl; 1985; 178():15-23. PubMed ID: 3867116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrinolysis and thrombolytic therapy under laboratory control].
    Osten W
    Med Lab (Stuttg); 1966 May; 19(5):108-13 contd. PubMed ID: 5982109
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological potentials for activating the fibrinolytic system].
    Markwardt F
    Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.
    Carter BL; Jones ME; Waickman LA
    Clin Pharm; 1985; 4(3):279-96. PubMed ID: 3891200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of laboratory diagnosis in thrombolytic therapy].
    Ostermann H; Kienast J
    Internist (Berl); 1992 Apr; 33(4):252-7. PubMed ID: 1612849
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood coagulation: hemostasis and thrombin regulation.
    Tanaka KA; Key NS; Levy JH
    Anesth Analg; 2009 May; 108(5):1433-46. PubMed ID: 19372317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgical hemorrhagic syndrome. Elaboration of a practical procedure of investigation and treatment in the absence of a specialized laboratory].
    Otteni JC; Boyer C; Girardel JM; Gauthier-Lafaye JP
    Anesth Analg (Paris); 1969; 26(1):89-106. PubMed ID: 5793321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.